Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beibei Fu

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Clinical and Translational Medicine|January 13, 2023
Small molecule Z363 co-regulates TAF10 and MYC via the E3 ligase TRIP12 to suppress tumour growthYan Xiong, Lulu Wang, Shiyao Xu, et al.
Cell Host & Microbe|November 25, 2021
Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2Haibo Wu, Na Xing, Kaiwen Meng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 13, 2025
Bacteroides Fragilis Transplantation Reverses Reproductive Senescence by Transporting Extracellular Vesicles Through the Gut-Ovary AxisYan Xiong, Xiaoxue Lu, Bohao Li, et al.
Journal of Affective Disorders|August 1, 2020
The mental health of frontline and non-frontline medical workers during the coronavirus disease 2019 (COVID-19) outbreak in China: A case-control studyQi Cai, Hongliang Feng, Jing Huang, et al.
Plasmid|September 12, 2018
Development of a Gateway-compatible pCAMBIA binary vector for RNAi-mediated gene knockdown in plantsDeshui Yu, Libing Liao, Yi Zhang, et al.
Cancer Biology & Therapy|January 27, 2016
EBI-907, a novel BRAF(V600E) inhibitor, has potent oral anti-tumor activity and a broad kinase selectivity profileJiayin Zhang, Biao Lu, Dong Liu, et al.
EMBO Reports|July 21, 2021
MiR-342 controls Mycobacterium tuberculosis susceptibility by modulating inflammation and cell deathBeibei Fu, Xiaoyuan Lin, Shun Tan, et al.
Iscience|March 16, 2021
ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathwayXiaoyuan Lin, Beibei Fu, Songna Yin, et al.
Plos One|June 26, 2025
SHR-A1811, a novel anti-HER2 antibody-drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profilesTing Zhang, Jianyan Xu, Junzhao Yin, et al.
NPJ Precision Oncology|January 25, 2024
A multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugsChangwen Wang, Meng Sun, Chunxuan Shao, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Clinical and Translational Medicine|January 13, 2023
Small molecule Z363 co-regulates TAF10 and MYC via the E3 ligase TRIP12 to suppress tumour growthYan Xiong, Lulu Wang, Shiyao Xu, et al.
Cell Host & Microbe|November 25, 2021
Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2Haibo Wu, Na Xing, Kaiwen Meng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 13, 2025
Bacteroides Fragilis Transplantation Reverses Reproductive Senescence by Transporting Extracellular Vesicles Through the Gut-Ovary AxisYan Xiong, Xiaoxue Lu, Bohao Li, et al.
Journal of Affective Disorders|August 1, 2020
The mental health of frontline and non-frontline medical workers during the coronavirus disease 2019 (COVID-19) outbreak in China: A case-control studyQi Cai, Hongliang Feng, Jing Huang, et al.
Plasmid|September 12, 2018
Development of a Gateway-compatible pCAMBIA binary vector for RNAi-mediated gene knockdown in plantsDeshui Yu, Libing Liao, Yi Zhang, et al.
Cancer Biology & Therapy|January 27, 2016
EBI-907, a novel BRAF(V600E) inhibitor, has potent oral anti-tumor activity and a broad kinase selectivity profileJiayin Zhang, Biao Lu, Dong Liu, et al.
EMBO Reports|July 21, 2021
MiR-342 controls Mycobacterium tuberculosis susceptibility by modulating inflammation and cell deathBeibei Fu, Xiaoyuan Lin, Shun Tan, et al.
Iscience|March 16, 2021
ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathwayXiaoyuan Lin, Beibei Fu, Songna Yin, et al.
Plos One|June 26, 2025
SHR-A1811, a novel anti-HER2 antibody-drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profilesTing Zhang, Jianyan Xu, Junzhao Yin, et al.
NPJ Precision Oncology|January 25, 2024
A multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugsChangwen Wang, Meng Sun, Chunxuan Shao, et al.
Pageof 7